Gut · 1975 · 101 citations · 8 references
MedicineEndocrinologyPharmacologyBiochemical PharmacologyClinical PharmacologyPharmacodynamicsEndocrine PharmacologyGastric DiseasesGastric DisordersGastrointestinal PathophysiologyGastrointestinal PharmacologyHormone SecretionAcid Secretion InhibitionDose ResponseGastric Enzyme SecretionGastric SecretionGastric Secretory PhysiologyGastrin SecretionHistamine-mediated SecretionIntrinsic Factor Physiology
Purified human urogastrone was given by intravenous infusion to 12 normal volunteer subjects and measurements made of gastric acid, pepsin and intrinsic factor secretion, and of plasma gastrin concentration. Clinical, haematological, and biochemical screening tests were made throughout the period of study. Urogastrone inhibited acid and intrinsic factor secretion whether stimulated by pentagastrin, histamine, or insulin, but had a much less marked effect on gastric pepsin output. Plasma gastrin levels did not alter significantly. Limited dose-response studies showed that 0-25 mug urogastrone kg--1 hr--1 resulted in inhibition of acid output of 80% and was not associated with clinical side-effects. No significant alteration in any of the haematological or biochemical measurements was observed in any of the subjects.
8
Skin lesions, angioedema, and hypocomplementemia
J. G. P. Sissons · The Lancet · 1974 · 151 citations
Medicine, Dermatology, Hematology +12
Radio‐immunoassay of gastrin in human plasma
P. C. Ganguli, W. M. Hunter · The Journal of Physiology · 1972 · 69 citations
EFFECT OF UROGASTRONE IN THE ZOLLINGER-ELLISON SYNDROME
J B Elder, I. E. Gillespie, P. C. Ganguli et al. · The Lancet · 1975 · 36 citations
Preparation of Pyrogen-Free Urogastrone.
John S. Gray, C. U. Culmer, E. Wieczorowski et al. · Experimental Biology and Medicine · 1940 · 26 citations